ATE252371T1 - Verfahren für die herstellung einer biologisch aktiven zusammensetzung - Google Patents

Verfahren für die herstellung einer biologisch aktiven zusammensetzung

Info

Publication number
ATE252371T1
ATE252371T1 AT99927062T AT99927062T ATE252371T1 AT E252371 T1 ATE252371 T1 AT E252371T1 AT 99927062 T AT99927062 T AT 99927062T AT 99927062 T AT99927062 T AT 99927062T AT E252371 T1 ATE252371 T1 AT E252371T1
Authority
AT
Austria
Prior art keywords
biologically active
active agent
carrier
producing
chemical operation
Prior art date
Application number
AT99927062T
Other languages
English (en)
Inventor
Ke Lindahl
H Kan Hagslaett
Catharina Heiman
Rickard Bryland
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Application granted granted Critical
Publication of ATE252371T1 publication Critical patent/ATE252371T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT99927062T 1998-05-14 1999-05-12 Verfahren für die herstellung einer biologisch aktiven zusammensetzung ATE252371T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000824 WO1999058109A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (1)

Publication Number Publication Date
ATE252371T1 true ATE252371T1 (de) 2003-11-15

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99927062T ATE252371T1 (de) 1998-05-14 1999-05-12 Verfahren für die herstellung einer biologisch aktiven zusammensetzung

Country Status (20)

Country Link
EP (1) EP1077677B1 (de)
JP (1) JP2002514588A (de)
KR (1) KR100766998B1 (de)
CN (1) CN1309554A (de)
AT (1) ATE252371T1 (de)
AU (1) AU742921B2 (de)
CA (1) CA2332110A1 (de)
DE (2) DE1077677T1 (de)
DK (1) DK1077677T3 (de)
ES (1) ES2155049T3 (de)
GR (1) GR20010300014T1 (de)
HU (1) HUP0102002A3 (de)
IL (2) IL139577A0 (de)
NO (1) NO20005725L (de)
NZ (1) NZ508074A (de)
PL (1) PL344221A1 (de)
SE (1) SE9801705D0 (de)
TR (1) TR200003588T2 (de)
WO (1) WO1999058109A1 (de)
ZA (1) ZA200006476B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064149A1 (en) * 2000-02-29 2001-09-07 Jie Zhang Improved transdermal drug patch
AU2004263130A1 (en) * 2003-08-06 2005-02-17 Nirmal Mulye Pharmaceutical composition containing water soluble drug
JP2009540019A (ja) 2006-06-14 2009-11-19 ドクター・レディーズ・ラボラトリーズ・リミテッド 局所組成物
CN103080185B (zh) * 2010-08-31 2015-07-01 巴斯夫欧洲公司 基于柠檬酸的支化聚酯、其制备及应用
BR112013017953A2 (pt) * 2011-01-13 2017-08-29 Quadra Logic Tech Inc Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
NO20005725L (no) 2001-01-11
AU742921B2 (en) 2002-01-17
DE1077677T1 (de) 2001-09-20
KR100766998B1 (ko) 2007-10-15
CN1309554A (zh) 2001-08-22
IL139577A0 (en) 2002-02-10
DE69912271D1 (de) 2003-11-27
PL344221A1 (en) 2001-10-08
EP1077677A1 (de) 2001-02-28
ZA200006476B (en) 2001-06-11
SE9801705D0 (sv) 1998-05-14
DE69912271T2 (de) 2004-08-26
NZ508074A (en) 2003-01-31
AU4405199A (en) 1999-11-29
HUP0102002A3 (en) 2002-12-28
EP1077677B1 (de) 2003-10-22
IL139577A (en) 2007-07-04
HUP0102002A2 (hu) 2002-03-28
ES2155049T1 (es) 2001-05-01
DK1077677T3 (da) 2004-02-16
JP2002514588A (ja) 2002-05-21
WO1999058109A1 (en) 1999-11-18
CA2332110A1 (en) 1999-11-18
TR200003588T2 (tr) 2001-06-21
GR20010300014T1 (en) 2001-04-30
ES2155049T3 (es) 2004-05-16
KR20010052349A (ko) 2001-06-25
NO20005725D0 (no) 2000-11-13

Similar Documents

Publication Publication Date Title
DE69722963D1 (de) Verfahren zur herstellung von vorrichtungen für kontrollierte freisetzung
ATE204466T1 (de) Zusammensetzung, die ein in einem glasbildenden träger gelösten wirkstoff enthalt und ein verfahren zu deren herstellung
ATE204469T1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln
ATE113609T1 (de) Material aus karboxylgruppen enthaltenden polysacchariden, sowie verfahren zur herstellung solcher polysaccharide.
JPS54101795A (en) Hydrophobic rendering method for oxide fine powder
DE69124357T2 (de) Protein Nanomatrizen und Verfahren zur Herstellung
CA2407684A1 (en) Hematology blood control and method for preparation of same
DE60111412D1 (de) Verfahren zur herstellung einer emulsion, deren organische phase eine hohe viskosität hat
ATE326437T1 (de) Beschichtungszusammensetzung, insbesondere für glasoberflächen, und verfahren zu deren herstellung und verwendung
DE69912271D1 (de) Verfahren für die herstellung einer biologisch aktiven zusammensetzung
DE69934212D1 (de) Integrierte additivzusammensetzung, verfahren zu ihrer herstellung sowie deren verwendung
DE69815358D1 (de) Verfahren zur maskierung von in emulsion vorliegenden polyisocyanaten
GB2315745A (en) Hydraulic cement set accelerators based on nitroalcohols
ATE310500T1 (de) Biologisch aktive zusammensetzung
DE50008528D1 (de) Verfahren zur herstellung von gamma-butyrolacton
ATE240986T1 (de) Verfahren zur herstellung eines schaumstoffes
ATE36723T1 (de) Gefrierschutz- und bodenverbesserungsmittel, sowie verfahren zu seiner herstellung.
KR910002493A (ko) 다공질화산암(多孔質火山岩)을 활용한 공해방지제 (公害防止劑)의 제조방법
NZ512530A (en) Composition including citric acid and an organic thickening agent, and a method for removing a cementitious substance (e.g. concrete) from a surface

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1077677

Country of ref document: EP